Skip to main content
Clinical Trials/NCT01359540
NCT01359540
Completed
N/A

A Dual Energy X-Ray Absorptiometry (DXA) Evaluation Of Bone Density Changes After Hip Replacement. Performance Of The OMNI Apex Modular™ Hip Stem And The OMNI Apex ARC™ Hip Stem In Primary Total Hip Arthroplasty, Five-Year Clinical And DXA Analysis

Spokane Joint Replacement Center1 site in 1 country73 target enrollmentNovember 2009

Overview

Phase
N/A
Intervention
Not specified
Conditions
Osteoarthritis, Hip
Sponsor
Spokane Joint Replacement Center
Enrollment
73
Locations
1
Primary Endpoint
Femoral bone mineral density
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

This study compares the change in bone density which occurs after hip replacement with different femoral stem devices.

Registry
clinicaltrials.gov
Start Date
November 2009
End Date
April 2018
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Spokane Joint Replacement Center
Responsible Party
Principal Investigator
Principal Investigator

David F. Scott, MD

Principle Investigator

Spokane Joint Replacement Center

Eligibility Criteria

Inclusion Criteria

  • Minimum age 20 years, maximum age 80 years
  • Osteoarthritis of the hip
  • Elective THA
  • Signed Informed Consent

Exclusion Criteria

  • Osteoporosis
  • Revisions
  • Clinically obese (\>40 body mass index \[BMI\])
  • Femoral dysplasia
  • Trochanteric osteotomy
  • Inflammatory arthritis
  • Breast-feeding, pregnancy, or women of childbearing potential without documentation of a negative pregnancy test and not utilizing contraception
  • Patients with a history of having taken or currently taking bisphosphonates, PTH, fluoride therapy or strontium ranelate or patients taking other chronic medications that in the investigator's opinion are known to affect bone mineral density in a substantial way
  • Patients with severe medical condition(s) that in the view of the investigator prohibits participation in the study
  • Use of other investigational agent in the last 30 days

Outcomes

Primary Outcomes

Femoral bone mineral density

Time Frame: Baseline, 6 weeks, 6 months, 1, 2, 3, 4, and 5 years post-operative

Change in bone mineral density (BMD) as measured by DXA imaging.

Secondary Outcomes

  • Harris Hip Score (HHS)(Pre-operative, 6 weeks, 6 months, 1, 2, 3, 4, and 5 years post-operative)

Study Sites (1)

Loading locations...

Similar Trials